Citation Impact
Citing Papers
Neutralizing antibody response during acute and chronic hepatitis C virus infection
2004 StandoutNobel
Complete Replication of Hepatitis C Virus in Cell Culture
2005 StandoutScienceNobel
Shortwave infrared fluorescence imaging with the clinically approved near-infrared dye indocyanine green
2018 StandoutNobel
Sequence- and Structure-Specific RNA Processing by a CRISPR Endonuclease
2010 StandoutScienceNobel
Genome sequence of an industrial microorganism Streptomyces avermitilis : Deducing the ability of producing secondary metabolites
2001 StandoutNobel
Evidence for a functional RNA element in the hepatitis C virus core gene
2007 StandoutNobel
Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1)
2013 StandoutNobel
Three conformational snapshots of the hepatitis C virus NS3 helicase reveal a ratchet translocation mechanism
2009 StandoutNobel
Identification of Genes Selectively Regulated by IFNs in Endothelial Cells
2007
Target-conditioned diffusion generates potent TNFR superfamily antagonists and agonists
2024 StandoutScienceNobel
Structures of the RNA-guided surveillance complex from a bacterial immune system
2011 StandoutNatureNobel
Cellular Binding of Hepatitis C Virus Envelope Glycoprotein E2 Requires Cell Surface Heparan Sulfate
2003
Early antibody response against hypervariable region 1 is associated with acute self-limiting infections of hepatitis C virus
1997
SEC14L2 enables pan-genotype HCV replication in cell culture
2015 StandoutNatureNobel
Stem cells, cancer, and cancer stem cells
2001 StandoutNature
Completion of the entire hepatitis C virus life cycle in genetically humanized mice
2013 StandoutNatureNobel
Unravelling hepatitis C virus replication from genome to function
2005 StandoutNatureNobel
Vaccination with an adenoviral vector encoding hepatitis C virus (HCV) NS3 protein protects against infection with HCV-recombinant vaccinia virus
2002
Binding of the hepatitis C virus envelope protein E2 to CD81 provides a co-stimulatory signal for human T cells
2001
Identification of genes that are associated with DNA repeats in prokaryotes
2002
Hepatitis C virus envelope glycoprotein immunization of rodents elicits cross-reactive neutralizing antibodies
2007 StandoutNobel
Vaccination of Chimpanzees With Plasmid DNA Encoding the Hepatitis C Virus (HCV) Envelope E2 Protein Modified the Infection After Challenge With Homologous Monoclonal HCV
2000
Hepatitis C virus entry: Molecular biology and clinical implications
2006
CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III
2011 StandoutNatureNobel
Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge
2007
Cellular glycosaminoglycans and low density lipoprotein receptor are involved in hepatitis C virus adsorption
2002
Characterization of Human Monoclonal Antibodies Specific to the Hepatitis C Virus Glycoprotein E2 within VitroBinding Neutralization Properties
1998
Prospects for a vaccine against the hepatitis C virus
2005 StandoutNatureNobel
The SEED and the Rapid Annotation of microbial genomes using Subsystems Technology (RAST)
2013 Standout
High titers of antibodies inhibiting the binding of envelope to human cells correlate with natural resolution of chronic hepatitis C
1998 StandoutNobel
Molecular Characterization of Hepatitis C Virus
1998 StandoutNobel
Adaptive Immunity to the Hepatitis C Virus
2010
Regulation of CC chemokine receptor 5 in Hepatitis G virus infection
2003
Cell Cycle Control by an Essential Bacterial Two-Component Signal Transduction Protein
1996
Hepatitis C Virus: Epidemiology, Transmission and Prevention
1998
RNA-guided genetic silencing systems in bacteria and archaea
2012 StandoutNatureNobel
Human occludin is a hepatitis C virus entry factor required for infection of mouse cells
2009 StandoutNatureNobel
Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry
2007 StandoutNatureNobel
A diverse range of gene products are effectors of the type I interferon antiviral response
2011 StandoutNatureNobel
Characterization of the hepatitis C virus E2 epitope defined by the broadly neutralizing monoclonal antibody AP33
2006
The biosynthetic gene cluster for the antitumor drug bleomycin from Streptomyces verticillus ATCC15003 supporting functional interactions between nonribosomal peptide synthetases and a polyketide synthase
2000
CASK Functions as a Mg2+-Independent Neurexin Kinase
2008 StandoutNobel
The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus
2002
Biology and Applications of CRISPR Systems: Harnessing Nature’s Toolbox for Genome Engineering
2016 StandoutNobel
Immunization of chimpanzees with an envelope protein-based vaccine enhances specific humoral and cellular immune responses that delay hepatitis C virus infection
2003
Crystal Structure of the Hepatitis C Virus NS3 Protease Domain Complexed with a Synthetic NS4A Cofactor Peptide
1996 StandoutNobel
Recovery, Persistence, and Sequelae in Hepatitis C Virus Infection: A Perspective on Long-Term Outcome
2000
Characterization of Pseudotype VSV Possessing HCV Envelope Proteins
2001
The Biology of CRISPR-Cas: Backward and Forward
2018 StandoutNobel
A genetically humanized mouse model for hepatitis C virus infection
2011 StandoutNatureNobel
Transmission in vitro of hepatitis C virus from persistently infected human B-cells to hepatoma cells by cell-to-cell contact
2005
Novel Insights into Hepatitis C Virus Replication and Persistence
2004
Nucleotide binding by the histidine kinase CheA.
2001
Selective Targeting of TNF Receptors as a Novel Therapeutic Approach
2020
Replication of hepatitis C virus
2007 StandoutNobel
Analysis of Antigenicity and Topology of E2 Glycoprotein Present on Recombinant Hepatitis C Virus-Like Particles
2002
The B-cell receptor of a hepatitis C virus (HCV)–associated non-Hodgkin lymphoma binds the viral E2 envelope protein, implicating HCV in lymphomagenesis
2001
Induction of Broad CD4+and CD8+T-Cell Responses and Cross- Neutralizing Antibodies against Hepatitis C Virus by Vaccination with Th1-Adjuvanted Polypeptides Followed by Defective Alphaviral Particles Expressing Envelope Glycoproteins gpE1 and gpE2 and Nonstructural Proteins 3, 4, and 5
2008 StandoutNobel
Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles
2003 StandoutNobel
Evaluation of Hepatitis C Virus Glycoprotein E2 for Vaccine Design: an Endoplasmic Reticulum-Retained Recombinant Protein Is Superior to Secreted Recombinant Protein and DNA-Based Vaccine Candidates
2000 StandoutNobel
Functional Analysis of Cell Surface-Expressed Hepatitis C Virus E2 Glycoprotein
1999
Replication of hepatitis C virus
2000
Characterization of truncated forms of hepatitis C virus glycoproteins.
1997 StandoutNobel
Definition of a Conserved Immunodominant Domain on Hepatitis C Virus E2 Glycoprotein by Neutralizing Human Monoclonal Antibodies
2008
The dynamics of hepatitis C virus binding to platelets and 2 mononuclear cell lines
2001
Binding of Hepatitis C Virus to CD81
1998 StandoutScienceNobel
Blocking Hepatitis C Virus Infection with Recombinant Form of Envelope Protein 2 Ectodomain
2009
Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors
2013 StandoutScienceNobel
Human Monoclonal Antibodies That React With the E2 Glycoprotein of Hepatitis C Virus and Possess Neutralizing Activity *
2005
Functional Role of Hepatitis C Virus Chimeric Glycoproteins in the Infectivity of Pseudotyped Virus
1998
Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus
2012 StandoutNobel
The new frontier of genome engineering with CRISPR-Cas9
2014 StandoutScienceNobel
Monoclonal Antibody AP33 Defines a Broadly Neutralizing Epitope on the Hepatitis C Virus E2 Envelope Glycoprotein
2005
Modeling hepatitis C virus infection using human induced pluripotent stem cells
2012 StandoutNobel
Expression of Noncovalent Hepatitis C Virus Envelope E1-E2 Complexes Is Not Required for the Induction of Antibodies with Neutralizing Properties following DNA Immunization
1999
Immunization with plasmid DNA encoding hepatitis C virus envelope E2 antigenic domains induces antibodies whose immune reactivity is linked to the injection mode
1997
Analysis of Antigenicity and Topology of E2 Glycoprotein Present on Recombinant Hepatitis C Virus-Like Particles
2002
Recombinant human monoclonal antibodies against different conformational epitopes of the E2 envelope glycoprotein of hepatitis C virus that inhibit its interaction with CD81
2000 StandoutNobel
Interactions of Indocyanine Green and Lipid in Enhancing Near-Infrared Fluorescence Properties: The Basis for Near-Infrared Imaging in Vivo
2014
Fluorescence bleaching reveals asymmetric compartment formation prior to cell division in Caulobacter
2003 StandoutNobel
Broadly neutralizing human monoclonal antibodies to the hepatitis C virus E2 glycoprotein
2008
Hepatitis C virus entry: potential receptors and their biological functions
2006
The Outcome of Acute Hepatitis C Predicted by the Evolution of the Viral Quasispecies
2000 Science
Analysis of a Highly Flexible Conformational Immunogenic Domain A in Hepatitis C Virus E2
2005
Binding of Hepatitis C Virus-Like Particles Derived from Infectious Clone H77C to Defined Human Cell Lines
2002
Viral Persistence, Antibody to E1 and E2, and Hypervariable Region 1 Sequence Stability in Hepatitis C Virus-Inoculated Chimpanzees
1999
Human Monoclonal Antibodies That Inhibit Binding of Hepatitis C Virus E2 Protein to CD81 and Recognize Conserved Conformational Epitopes
2000
Dynamic analysis of hepatitis C virus replication and quasispecies selection in long-term cultures of adult human hepatocytes infected in vitro
1999
Recognition of Native Hepatitis C Virus E1E2 Heterodimers by a Human Monoclonal Antibody
2002
Mapping B-Cell Epitopes of Hepatitis C Virus E2 Glycoprotein Using Human Monoclonal Antibodies from Phage Display Libraries
2001
Activation of naïve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders
2005 StandoutNobel
A Point Mutation Leading to Hepatitis C Virus Escape from Neutralization by a Monoclonal Antibody to a Conserved Conformational Epitope
2008
Hepatitis C Virus Glycoproteins Interact with DC-SIGN and DC-SIGNR
2003 StandoutNobel
Folding of Hepatitis C Virus E1 Glycoprotein in a Cell-Free System
2001 StandoutNobel
The dynamics of hepatitis C virus binding to platelets and 2 mononuclear cell lines
2001
Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures
2010 StandoutNobel
Structure-Function Analysis of Hepatitis C Virus Envelope-CD81 Binding
2000 StandoutNobel
Mutations in Hepatitis C Virus E2 Located outside the CD81 Binding Sites Lead to Escape from Broadly Neutralizing Antibodies but Compromise Virus Infectivity
2009 StandoutNobel
Hepatitis C virus lacking the hypervariable region 1 of the second envelope protein is infectious and causes acute resolving or persistent infection in chimpanzees
2000
Characterization of Hepatitis C Virus E2 Glycoprotein Interaction with a Putative Cellular Receptor, CD81
1999
Rewriting a genome
2013 StandoutNatureNobel
Structural basis of hepatitis C virus neutralization by broadly neutralizing antibody HCV1
2012
Functional Characterization of Intracellular and Secreted Forms of a Truncated Hepatitis C Virus E2 Glycoprotein
2000
Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein
1996
Characterization of an Immunodominant Antigenic Site on GB Virus C Glycoprotein E2 That Is Involved in Cell Binding
2006 StandoutNobel
Binding of the Hepatitis C Virus E2 Glycoprotein to CD81 Is Strain Specific and Is Modulated by a Complex Interplay between Hypervariable Regions 1 and 2
2003
Phosphorylation of hepatitis C virus nonstructural protein 5A modulates its protein interactions and viral RNA replication
2004 StandoutNobel
Structure of the catalytic domain of the hepatitis C virus NS2-3 protease
2006 StandoutNatureNobel
Sexual transmission of the hepatitis C virus and efficacy of prophylaxis with intramuscular immune serum globulin. A randomized controlled trial.
1997
Works of Eric Guenzi being referenced
Characterization of the Syringomycin Synthetase Gene Cluster
1998
Coordinate Transcription and Physical Linkage of Domains in Surfactin Synthetase Are Not Essential for Proper Assembly and Activity of the Multienzyme Complex
1998
A two‐component signal‐transducing system is involved in competence and penicillin susceptibility in laboratory mutants of Streptococcus pneumoniae
1994
The helical domain of GBP-1 mediates the inhibition of endothelial cell proliferation by inflammatory cytokines
2001
The guanylate binding protein-1 GTPase controls the invasive and angiogenic capability of endothelial cells through inhibition of MMP-1 expression
2003
Antagonistic TNF Receptor One-Specific Antibody (ATROSAB): Receptor Binding and In Vitro Bioactivity
2013
A highly conserved repeated DNA element located in the chromosome ofStreptococcus pneumoniae
1992
Essential protective role of tumor necrosis factor receptor 2 in neurodegeneration
2016
FRI0231 Atrosab, a humanized antibody directed against tnf-receptor 1, hold great promises for the treatment of rheumatoid arthritis
2013
A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells.
1996 StandoutNobel
Guanylate-Binding Protein-1 Expression Is Selectively Induced by Inflammatory Cytokines and Is an Activation Marker of Endothelial Cells during Inflammatory Diseases
2002
In vivo imaging of choroidal angiogenesis using fluorescence-labeled cationic liposomes.
2012
Nuclear factor-kappaB motif and interferon-alpha-stimulated response element co-operate in the activation of guanylate-binding protein-1 expression by inflammatory cytokines in endothelial cells
2004